Back to search

Boston University

Role of aortic carboxypeptidase-like protein in adipose tissue fibrosis

Abstract

dc:description.abstract

Obesity is a growing global health concern, with prevalence rates more than doubling since 1990. It is a major risk factor for numerous comorbidities, including hypertension, type 2 diabetes, cardiovascular disease, dementia, and an increased likelihood of developing cancer. Obesity is characterized by excessive adipose tissue expansion, with white adipose tissue (WAT) being the most extensively studied type. WAT plays a critical role in energy storage, endocrine regulation, and metabolic homeostasis, demonstrating remarkable plasticity by transitioning between progenitor and differentiated states. However, when adipocytes undergo excessive hypertrophy, they exhibit fibrosis, inflammation, and metabolic dysfunction, ultimately leading to insulin resistance and systemic disease. The extracellular matrix (ECM) plays a pivotal role in adipose tissue remodeling, but excessive ECM deposition in fibrotic tissue disrupts normal metabolic function. As obesity progresses, adipose tissue expansion is frequently accompanied by fibrosis and chronic low-grade inflammation, both of which exacerbate metabolic dysfunction and contribute to obesity-related complications. Fibrosis, marked by excessive ECM accumulation, alters adipose tissue architecture and impairs adipocyte function, leading to metabolic dysregulation. Simultaneously, inflammation—driven by immune cell infiltration and the release of pro-inflammatory cytokines—further disrupts tissue homeostasis and promotes systemic insulin resistance. Given these pathological changes, understanding the molecular mechanisms that govern adipose tissue remodeling in obesity is essential. One key protein implicated in these processes is aortic carboxypeptidase-like protein (ACLP), which has been linked to fibrotic remodeling in various tissues. ACLP plays a crucial role in ECM dynamics by regulating collagen deposition, fibroblast activation, and tissue stiffening—hallmarks of fibrosis. In the adipose tissue, ACLP may serve as a key mediator connecting obesity-induced mechanical and inflammatory cues to fibrotic remodeling. Investigating its role in adipose tissue fibrosis could provide valuable insights into the interplay between ECM remodeling, inflammation, and metabolic dysfunction. The molecular pathways that drive fibrosis and inflammation in adipose tissue are crucial for identifying potential therapeutic targets to mitigate obesity-related complications. By further studying ACLP’s role and its downstream signaling mechanisms, we may uncover novel strategies to alleviate fibrotic burden and enhance adipose tissue plasticity, ultimately improving metabolic health.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Vejar, Crystal Denise
Advisors dc:contributor.advisor
  • Layne, Matthew D.
  • Pickering, Richard T.

Subjects

dc:subject × 9

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/52389

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Vejar, Crystal Denise. Role of aortic carboxypeptidase-like protein in adipose tissue fibrosis. masters thesis, Boston University, 2025. https://hdl.handle.net/2144/52389